CHAELIN KIM (@ckim0509) profile picture
Joined November 2014
CHAELIN KIM retweeted
Our framework that informed the @WHO TB & climate change policy brief out now in @LancetRespirMed, exploring the intersections and implications of climate change for the TB epidemic. Key message? TB should be considered a climate-sensitive disease thelancet.com/journals/lanreโ€ฆ
1
5
4
152
CHAELIN KIM retweeted
When fluoroquinolone resistance status is unknown, empirical use of BPaLM (adding moxifloxacin to BPaL) is cost-effective as a replacement for BPaL even with high fluoroquinolone resistance levels!๐Ÿฆ ๐Ÿ’Š doi.org/10.1371/journal.pgphโ€ฆ
1
5
4
242
Are you interested in #TB and have experience in #modelling infectious diseases? Come join us in the fun, supportive, and world-leading TB Modelling Group at @LSHTM ! We have a 1 year Research Fellow position (with possible extension) Closing date of 30 May 2025 ๐Ÿ‘‰ jobs.lshtm.ac.uk/vacancy.aspโ€ฆ
11
16
1,128
CHAELIN KIM retweeted
Are pan-TB treatment regimens likely to drive the emergence of novel drug resistance? We investigated, in a new paper here wwwnc.cdc.gov/eid/article/30โ€ฆ with @emilyakendall @NickMenzies2 @richardwhite321 @ted_h_cohen @rycktessman @LSHTM @LSHTM_TB @cmmid_lshtm @lshtm_tbmod
1
11
13
1,441
Subclinical tuberculosis is ~half of prevalent TB, could make people sick and cause transmission So, it is crucial to understand whether new TB vaccines prevent subclinical TB and what it means for global impact Find out how more in our new paper in @LancetMicrobe rb.gy/yrtnyt
2
25
1
56
5,828
@CFMcQuaid of the @LSHTM_TB and @tb_mac is keen to develop decision support tools for TB treatment but is hampered by data on drug susceptibility testing as well as on AMR prevalence.
4
11
620
CHAELIN KIM retweeted
Great to see this thought piece out! For so many TB drugs DST is still not widely available - to support clinicians, policymakers must provide pragmatic treatment recommendations for situations where resistance profile is unknown. So what should they do? erj.ersjournals.com/content/โ€ฆ
1
9
13
2,010
This week in #KnightGroup, @NaomiMFuller has shared her, Alastair's, and @QuentinLclrc's experience at the recent๐Ÿฆ Epidemics conference in Italy๐Ÿ‡ฎ๐Ÿ‡น! Interesting discussions on privilege in research and effective peer critique.๐Ÿ’ก๐Ÿง
6
46
Who knew a meet up of TB modellers could be so much fun! Such a wonderful bunch of bright, open and friendly folks, dedicated to ending TB I'd be willing to bet that some new collaborations were formed. Thanks to BMGF for funding #Unionconference @tb_mac โ€“ at Paris, France
5
2
44
3,276
์Šคํ…Œ๋”” ์—˜๋ผ์˜ 'ChatGPT๋ฅผ ํ™œ์šฉํ•œ ๋Œ€ํ•™์› ์ƒํ™œ ์„ธ๋ฏธ๋‚˜' ์„ค๋ฌธ์กฐ์‚ฌ๋ฅผ ์ง„ํ–‰ํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค!๐Ÿ“‹ ์„ค๋ฌธ์กฐ์‚ฌ๋ฅผ ์ง„ํ–‰ํ•ด์ฃผ์‹œ๋ฉด, ์„ธ๋ฏธ๋‚˜ ์˜คํ”ˆ ์‹œ ๋ฐ”๋กœ ์‹ ์ฒญ์„œ๋ฅผ ์ „๋‹ฌ๋“œ๋ฆฌ๊ฒ ์Šต๋‹ˆ๋‹ค๐Ÿ™Œ๐Ÿป ChatGPT๋ฅผ ํ™œ์šฉํ•ด์„œ ๋Œ€ํ•™์› ์ƒํ™œํ•˜๊ธฐ ์„ธ๋ฏธ๋‚˜๊ฐ€ ๋ญ”์ง€ ๊ถ๊ธˆํ•˜์‹œ๋‹ค๋ฉด ์•„๋ž˜ ๋งํฌ๋กœ๐Ÿ”ฝ m.blog.naver.com/ella_enchanโ€ฆ
2
1
276
๋น ๋ฅธ ๊ตฌ๋… ์‹ ์ฒญ์€ ์•„๋ž˜ ๋งํฌ์—์„œ ๋ถ€ํƒ๋“œ๋ ค์š”๐Ÿ™Œ๐Ÿป page.stibee.com/subscriptionโ€ฆ ๋ฉ”์ผ ์ฃผ์†Œ๋งŒ ๊ธฐ์ž…ํ•˜์‹œ๋ฉด ์‹ ์ฒญ ์™„๋ฃŒ์ž…๋‹ˆ๋‹ค!๐Ÿ’Œ ๋‹ฌ์— โœŒ๐Ÿป๋ฒˆ, 15์ผ๊ณผ 30์ผ์— ๋ฐ›์•„๋ณด์‹ค ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค:) ๋งŽ์€ ๊ด€์‹ฌ ๋ถ€ํƒ๋“œ๋ฆฝ๋‹ˆ๋‹ค๐Ÿซถ๐Ÿป
2
1
390
m.blog.naver.com/ella_enchanโ€ฆ ์ ค๋ผ(@ZJ_txt)๋‹˜๊ณผ ํ•จ๊ป˜ ํ•ด์™ธ ์œ ํ•™&์ทจ์ค€๊ธฐ๋ฅผ ์—์„ธ์ดํ˜•์‹์˜ ๋ ˆํ„ฐ๋กœ ๋ฐœํ–‰ ์˜ˆ์ •์ž…๋‹ˆ๋‹ค. ๋ ˆํ„ฐ ์ œ๋ชฉ์€ โ€œ์—˜๋ผ์™€ ์ ค๋ผ, ์œ ๋Ÿฝ์—์„œ ์‚ด์•„๋‚จ์„ ์ˆ˜ ์žˆ์„ ๊ฒƒ์ธ๊ฐ€?๐Ÿ‡ฌ๐Ÿ‡ง๐Ÿ‡ณ๐Ÿ‡ฑโ€์ž…๋‹ˆ๋‹ค. ๊ตฌ๋…ํ•˜์‹œ๋ฉด 10/30๋ถ€ํ„ฐ ๋ฐ›์•„๋ณด์‹ค ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค๐Ÿ’Œ ๊ตฌ๋… ์‹ ์ฒญ์€ ์•„๋ž˜ ๋งํฌ์—์„œ ๋ถ€ํƒ๋“œ๋ ค์š”๐Ÿซถ๐Ÿป
1
4
1
2
4,723
CHAELIN KIM retweeted
Very happy to say a big Croeso (welcome ๐Ÿด๓ ง๓ ข๓ ท๓ ฌ๓ ณ๓ ฟ) and congrats to @ckim0509 who has started an MRCLID PhD with @CFMcQuaid and me @LSHTM. Looking forward to some interesting work on modelling empiric regimens for TB!
1
7
391
A ๐Ÿ†•systematic review & meta-analysis of case-control studies provides important practical insights into effective #WASH components to control #TyphoidFever. ๐Ÿซง๐Ÿคฒ๐Ÿšพ ๐Ÿ”–๐Ÿ‘‰tinyurl.com/6pe37xay
2
1
2
558
New #AMR research in @GlobalHealthBMJ makes a case for increasing coverage of existing vaccines and developing new vaccines as an effectives means of reducing the spread of antimicrobial resistance โคต๏ธ gh.bmj.com/content/8/7/e0113โ€ฆ @WHO @LSHTM
Over half a million #AMR-associated deaths could be preventable using vaccines, shows new research in @GlobalHealthBMJ ๐Ÿ’‰ The team from @IVIHeadquarters, @WHO & @LSHTM say their predictions support the need for vaccine scale-up and development ๐Ÿ‘‰ lshtm.ac.uk/research/centresโ€ฆ
3
1
11
2,313
"Increased coverage of existing vaccines and development of new vaccines are effective means to reduce AMR, and this evidence should inform the full value of vaccine assessments." @IsabelFrost19 ๐Ÿ“ฃ New Research โžก๏ธ gh.bmj.com/content/8/7/e0113โ€ฆ
4
11
1,305
Over half a million #AMR-associated deaths could be preventable using vaccines, shows new research in @GlobalHealthBMJ ๐Ÿ’‰ The team from @IVIHeadquarters, @WHO & @LSHTM say their predictions support the need for vaccine scale-up and development ๐Ÿ‘‰ lshtm.ac.uk/research/centresโ€ฆ
25
4
45
9,362
Our interns & volunteers help overcome poverty issues of families. Improved cooking in Haiti is a focus. #GiveLocalWP
2
1